Ascendis Pharma A/S (ASND)

ASND trades at $197.97, 10.0% above the near-term max pain of $180 expiring Aug 15, 2025 (0 days). Expect downward pressure as dealers benefit from price declining toward max pain. Max pain is rising across expirations ($140-$260), reflecting growing call interest at higher strikes. Key magnetic zone at 170 where 4 expirations converge. High dispersion in max pain levels suggests competing forces and potential volatility.

Max pain for ASND shows an upward trend from 140 to 260, suggesting bullish positioning in longer-dated options. The 67% spread signals divergent expectations across timeframes. Most levels below 197.97 may cap rallies. Strong magnetic level at 170 (4 expirations). Weekly expirations influence price 2-3 days before expiry; monthlies throughout their final week.